Xencor (XNCR) Change in Receivables (2016 - 2026)
Xencor's (XNCR) quarterly Change in Receivables came in at -$5.8 million in Q1 2026, up 75.22% year-on-year from -$3.3 million in Q1 2025, and up 75.22% on a QoQ basis from -$23.4 million in Q1 2025.
Xencor (XNCR) Change in Receivables (2016 - 2026) Analysis & Trends
Xencor (XNCR) has 9 years of Change in Receivables data on file, last reported at -$5.8 million in Q1 2026.
- On a quarterly basis, Change in Receivables rose 75.22% year-over-year to -$5.8 million in Q1 2026; TTM through Mar 2026 was -$77.5 million, a 72.63% decrease from a year earlier, with the FY2025 full-year figure at -$28.7 million, down 187.94% from the prior year.
- Change in Receivables for Q1 2026 stood at -$5.8 million, up from -$23.4 million in the prior quarter.
- Over the last five years, Change in Receivables for XNCR reached as high as $26.8 million in Q1 2022 and fell as low as -$38.9 million in Q2 2022.
- Historically, Change in Receivables has averaged -$10.1 million across 3 years, with a median of -$9.4 million in 2022.
- On a YoY basis, Change in Receivables climbed as much as 2378.74% in 2022 and fell as far as 301.24% in 2022.
- Year by year, Change in Receivables stood at -$9.4 million in 2022, then plunged by 148.78% to -$23.4 million in 2025, then soared by 75.22% to -$5.8 million in 2026.
- Per Business Quant data, the three most recent Change in Receivables figures were -$5.8 million in Q1 2026, -$23.4 million in Q1 2025, and -$9.4 million in Q3 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 75.30 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 2.84 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -39.80 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Xencor | 1.47 Bn | 1.09 Bn | - | -5.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.80 Mn |
| Mar 31, 2026 | -5.80 Mn |
| Mar 31, 2025 | -23.41 Mn |
| Mar 31, 2025 | -23.41 Mn |
| Sep 30, 2022 | -9.41 Mn |
| Sep 30, 2022 | -9.41 Mn |
| Jun 30, 2022 | -38.92 Mn |
| Jun 30, 2022 | -38.92 Mn |
| Mar 31, 2022 | 26.82 Mn |
| Mar 31, 2022 | 26.82 Mn |
| Dec 31, 2021 | 58.34 Mn |
| Dec 31, 2021 | 58.34 Mn |
| Sep 30, 2021 | 5.22 Mn |
| Sep 30, 2021 | 5.22 Mn |
| Jun 30, 2021 | -9.70 Mn |
| Jun 30, 2021 | -9.70 Mn |
| Mar 31, 2021 | 1.08 Mn |
| Mar 31, 2021 | 1.08 Mn |
| Dec 31, 2020 | 1.91 Mn |
| Dec 31, 2020 | 1.91 Mn |